50 gram oral glucose challenge test combined with risk factor-based screening for gestational diabetes

https://doi.org/10.1016/j.ejogrb.2004.10.008Get rights and content

Abstract

Objective:

Our aim was to study whether universal screening of all pregnant women by Oral Glucose Challenge Test (OGCT) would identify a higher number of women with Gestational Diabetes (GDM) than risk factor based screening.

Study design:

A 50 g OGCT test was performed prospectively in 532 unselected women at 26–28 weeks of gestation. The 1-h venous plasma glucose concentration of >7.3 mmol/l was considered as a positive screening result. Patients with a positive OGCT underwent a 75 g 2-h OGTT, which was used as the actual diagnostic test for GDM. When two or all three of the glucose concentrations in OGTT (measured at fasting state and 1 and 2 h after the 75 g glucose load) were above the 97.5th percentile the patient was considered as having GDM. In addition, women with risk factors for GDM also underwent a 75 g OGTT regardless of the result of the OGCT.

Results:

A positive 50 g OGCT was obtained in 123 (23%) of the women. In 15 (12%) of these, a diagnosis of GDM was established by the subsequent OGTT. Out of the 409 remaining women with a normal OGCT, 148 (36%) had risk factors for GDM. An OGTT performed in these patients identified 4 additional women with a GDM. Seventy-nine percent of GDM was thus found with 50 g OGCT without regarding risk factors. Forty-seven percent of the women with GDM would have been missed in screening by risk factors only.

Conclusions:

In our population 50 g OGCT appears to identify a higher number of GDM than risk factor based screening. Combined with risk factor screening a few more cases of GDM would be found.

Introduction

There is evidence that even mild maternal hyperglycemia is a risk factor for fetal macrosomia, neonatal hypoglycemia and hyperbilirubinemia [1], [2], but these complications occur only in a minority of cases. The 2-h oral glucose tolerance test (OGTT) with only one abnormal value (defined as impaired glucose tolerance, IGT) has been shown to have minimal effects on perinatal outcome, at least when the patients adhere to an appropriate diet. An OGTT with two or three abnormal values, on the other hand, is associated with an increased risk for perinatal complications [3].

Failure to recognize gestational diabetes mellitus (GDM) may harm the fetus, whereas too aggressive screening results in many false-positive GDM diagnoses and subsequent unnecessary interventions.

The 50 g 1-h oral glucose challenge test (OGCT) remains the screening method of choice in North America. It is recommended by the American Diabetes Association (ADA) for women with risk factors [4]. In UK [5] and Northern Europe, the risk factor-based screening procedure followed by a 75 g OGTT as the diagnostic test is used. Universal screening with 50 g glucose load for all pregnant women has also been proposed [6], [7].

Our aim was to study whether universal screening of all pregnant women by OGCT would identify a higher number of GDM than risk factor based screening and how many more women with normal OGCT having risk factors would be diagnosed to have GDM.

Section snippets

Material and methods

Between January 1996 and August 1998, pregnant Caucasian women at primary health care units of the Western District of Helsinki were invited to participate. Approval of the local ethics committees was obtained, and a written consent was signed by the participating women. The exclusion criteria were pregestational type 1 and type 2 diabetes.

The 50 g OGCT was performed for all attendants at 26–28 weeks of gestation regardless to the fasting state. The 1-h venous plasma glucose concentration of >7.3

Results

Of a total of 620 patients recruited, 88 were excluded because of incomplete data, twin pregnancy, or delivery at another hospital district. The remaining 532 subjects were included in the final analysis. A positive 50 g OGCT was obtained in 123 (23%) women, of whom all had a 75 g OGTT. GDM was diagnosed in 15 (12%) of these 123 patients.

One hundred and forty-eight (36%) out of the 409 women with a normal OGCT had risk factors for GDM. Conforming to the study protocol, a 2-h OGTT was performed in

Discussion

In our study, 79% of patients with GDM were identified with universal 50 g OGCT screening test, and the remaining 21% by presence of risk factors for GDM in subjects with a normal 50 g OGCT. Nearly half (47%) of GDM would have been undiagnosed using risk factor-based screening only. This means that universal screening with 50 g OGCT can be complemented by taking into account the risk factors for GDM.

In a recent study of Östlund and Hanson, 29/61 of all GDM women and 4/21 among primiparas with GDM

Acknowledgements

The authors wish to acknowledge the skilful assistance of Hilkka Puttonen for performing the blood glucose analyses in this study. We also wish to thank the primary maternal health care units of the Western District of Helsinki for their co-operation.

References (12)

There are more references available in the full text version of this article.

Cited by (26)

  • Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: A systematic review and meta-analysis

    2021, Diabetes Research and Clinical Practice
    Citation Excerpt :

    Although prevalence might vary between studies, the main outcome, relative increase in prevalence should remain unaffected. Previous publications comparing the polycose test with risk factor screening showed that the polycose test is more predictive of GDM as a screening test [60,61]. However, our analyses included too few studies across each screening methodology to add further to this issue.

  • Prevalence of gestational diabetes mellitus in Europe: A meta-analysis

    2017, Diabetes Research and Clinical Practice
    Citation Excerpt :

    The search identified 3258 abstracts of which 161 were potentially relevant after title and abstract screening. The full text articles were retrieved and assessed against the inclusion criteria, resulting in 40 included studies reported in 41 papers [14–53] (additional papers: [54]). These 40 studies included a total of 1,778,399 participants.

  • Screening for gestational diabetes in low-risk women: Effect of maternal age

    2018, Hormone Molecular Biology and Clinical Investigation
View all citing articles on Scopus
View full text